Healthcare - Biotechnology - NASDAQ - US
$ 4.76
-5.18 %
$ 326 M
Market Cap
-1.25
P/E
BALANCE SHEET
517 M
ASSETS
84 M
LIABILITIES
433 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Amylyx Pharmaceuticals, Inc.
| Current Assets | 465 M |
| Cash & Short-Term Investments | 371 M |
| Receivables | 40 M |
| Other Current Assets | 53.3 M |
| Non-Current Assets | 52.8 M |
| Long-Term Investments | 0 |
| PP&E | 6.41 M |
| Other Non-Current Assets | 46.4 M |
| Current Liabilities | 82 M |
| Accounts Payable | 22.1 M |
| Short-Term Debt | 4.51 M |
| Other Current Liabilities | 55.5 M |
| Non-Current Liabilities | 1.98 M |
| Long-Term Debt | 1.98 M |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 170.2 | 62.5 | 50.2 | 12.9 | 3.1 |
| Short Term Investments | 201.2 | 284.4 | 45.9 | 0 | 0 |
| Receivables | 40.0 | 15.3 | 0 | 0 | 0 |
| Inventory | 38.3 | 9.8 | 0 | 0 | 0 |
| Other Current Assets | 14.9 | 10.1 | 8.8 | 0.8 | 0.1 |
| Total Current Assets | 464.7 | 382.1 | 101.5 | 13.6 | 3.2 |
| PP&E | 6.4 | 8.1 | 0.5 | 0.2 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0.7 | 0.2 | 0.2 | 0 |
| Other Long Term Assets | 46.4 | 0.5 | 3.4 | 0.1 | 18 K |
| Other Assets | 0 | 1 | 1 | 1 | 0 |
| Total Assets | 517.5 | 391.5 | 105.6 | 14.1 | 3.2 |
| LIABILITIES | |||||
| Accounts Payable | 22.1 | 6.3 | 4.4 | 3.6 | 2.2 |
| Short Term Debt | 4.5 | 4.1 | 0 | 0 | 0 |
| Other Current Liabilities | 55.5 | 36.3 | 13.0 | 3.7 | 2.3 |
| Total Current Liabilities | 82.0 | 46.6 | 17.4 | 7.3 | 4.5 |
| Long Term Debt | 2.0 | 4.2 | 0 | 1.4 | 14.9 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 35 K | 72.1 | 9.1 |
| Total Liabilities | 84.0 | 50.8 | 256.8 | 80.8 | 28.6 |
| EQUITY | |||||
| Common Stock | 7 K | 7 K | 1 K | 1 K | 1 K |
| Retained Earnings | (304.9) | (354.2) | (155.8) | (67.9) | (25.6) |
| Other Accumulative Comprehensive Income/Loss | 0.2 | 86 K | 9 K | (72.1) | (7.7) |
| Total Equity | 433.4 | 340.6 | (151.2) | (66.7) | (25.4) |
| Total Liabilities and Equity | 517.5 | 391.5 | 105.6 | 14.1 | 3.2 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 67.2 | 66.5 | 57.9 | 56.5 | 56.5 |